What We Do
Market leading software (SaaS) solutions
End-to-end management of your congress literature and assets - Resource Centre enables you to collate and share your digital scientific content to where it is needed: web portal, congress booth and virtual events.
Extending the reach of your clinical data - Nar8r enables authors to extend the reach of their research – enhancing their content by visually navigating and narrating to create a valuable video output.
How can we help you today?
Get in touch to learn more about our innovative solutions
Don't just take our word for it - here's what our customers say
Tangent90’s Trustrack has provided ‘one-click’ access to key scientific content for HCPs across 25 countries via the ViiV Exchange Portal.
Tangent90’s Trustrack has added value by driving consent capture and increasing rep engagement by 75% in first year, enabling wider digital roll-out across the company.
Tangent90’s innovative Nar8r solution enabled the conference organisers to provide a fully interactive event in a completely virtual environment.
Enabling pharma to drive better access and ongoing engagement with healthcare professionals (HCPs).
Tangent90 deliver agile digital solutions that enable pharmaceutical companies to fulfil customer needs across different channels and countries. Utilising our extensive knowledge of the life sciences industry and working with a network of trusted partners, we offer unique solutions which meet an unmet need and open up new opportunities. Our tools are scalable yet innovative, simplifying the often complex challenge of ensuring that scientific content is distributed compliantly.
We go beyond expectation, by delivering fast, cost-effective, copyright compliant content that meets the needs of HCPs, and enables the pharmaceutical industry to manage efficiencies and drive successful customer engagement.
Keep up to date on what's going on with Tangent90
Veeva recently published an eBook which discusses the best practice approach for supporting emerging pharma to launch and scale content faster. It focuses on how digital communications have allowed field teams to spend more quality time with HCPs. What can pharma’s brand teams do to support the increase needed?
We have been inundated with discussions about big data. Information that can help inform decision making is an output of nearly every phase in life sciences. The industry, with the increased use of digital channels, has been able to collect more data but is this being used to optimise their HCP engagement strategies?